New vessel formation in the central nervous system during tumor growth, vascular malformations, and Moyamoya

Current Neurovascular Research

Volumn 3, Issue 3, 2006, Pages 237-245

  Lim, Michael ^a   Cheshier, Samuel ^a   Steinberg, Gary K ^a,b  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Angiopoietins; Antiangiogenic therapies; AVMs; FGF; Integrins; Moyamoya disease; Vasculogenesis; VEGF

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOPOIETIN; ANTITHROMBOCYTIC AGENT; FIBROBLAST GROWTH FACTOR; INTEGRIN; MARIMASTAT; PEGINTERFERON ALPHA2B; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; THALIDOMIDE; VASCULOTROPIN;

ANGIOGENESIS; ARTERIOVENOUS MALFORMATION; BRAIN TUMOR; CAVERNOUS SINUS; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; CONGENITAL BLOOD VESSEL MALFORMATION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; MOYAMOYA DISEASE; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH; VASCULAR SURGERY;

ANGIOPOIETINS; ANIMALS; BRAIN; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM VASCULAR MALFORMATIONS; FIBROBLAST GROWTH FACTORS; HUMANS; INTEGRINS; MOYAMOYA DISEASE; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PLATELET-DERIVED GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33746906748     PISSN: 15672026     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720206778018730     Document Type: Review

References (102)

1. Abraham, J. A., Mergia, A., Whang, J. L., Tumolo, A., Friedman, J., Hjerrild, K. A., Gospodarowicz, D. and Fiddes, J. C. (1986a). Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. Science 233 (4763): 545-8.
2. Abraham, J. A., Whang, J. L., Tumolo, A., Mergia, A., Friedman, J., Gospodarowicz, D. and Fiddes, J. C. (1986b). Human basic fibroblast growth factor: nucleotide sequence and genomic organization. EMBO J 5 (10): 2523-8.
3. Aurrand-Lions, M., Johnson-Leger, C., Wong, C., Du Pasquier, L. and Imhof, B. A. (2001). Heterogeneity of endothelial junctions is reflected by differential expression and specific subcellular localization of the three JAM family members. Blood 98 (13): 3699-707.
4. Baev, N. I. and Awad, I. A. (1998). Endothelial cell culture from human cerebral cavernous malformations. Stroke 29 (11): 2426-34.
5. Baron, M. (2001). Induction of embryonic hematopoietic and endothelial stem/progenitor cells by hedgehog-mediated signals. Differentiation 68 (4-5): 175-85.
6. Berchem, G., Glondu, M., Gleizes, M., Brouillet, J. P., Vignon, F., Garcia, M. and Liaudet-Coopman, E. (2002). Cathepsin-D affects multiple tumor progression steps in vivo: Proliferation, angiogenesis and apoptosis. Oncogene 21 (38): 5951-5.
7. Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z. and Hanahan, D. (2000). Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2 (10): 737-44.
8. Brown, L. A., Rodaway, A. R., Schilling, T. F., Jowett, T., Ingham, P. W., Patient, R. K. and Sharrocks, A. D. (2000). Insights into early vasculogenesis revealed by expression of the ETS-domain transcription factor Fli-1 in wild-type and mutant zebrafish embryos. Mech Dev 90 (2): 237-52.
9. Carmeliet, P. (2000). Mechanisms of angiogenesis and arteriogenesis. Nat Med 6 (4): 389-95.
10. Carmeliet, P. (2004). Manipulating angiogenesis in medicine. J Intern Med 255 (5): 538-61.
11. Carmeliet, P. (2005). VEGF as a key mediator of angiogenesis in cancer. Oncology 69(Suppl 3): 4-10.
12. Carmeliet, P. and Collen, D. (1998). Vascular development and disorders: molecular analysis and pathogenic insights. Kidney Int 53 (6): 1519-49.
13. Childs, S., Chen, J. N., Garrity, D. M. and Fishman, M. C. (2002). Patterning of angiogenesis in the zebrafish embryo. Development 129 (4): 973-82.
14. Chiu, C. Y., Mathias, P., Nemerow, G. R. and Stewart, P. L. (1999). Structure of adenovirus complexed with its internalization receptor, alphavbeta5 integrin. J Virol 73 (8): 6759-68.
15. Conway, E. M. and Carmeliet, P. (2004). The diversity of endothelial cells: a challenge for therapeutic angiogenesis. Genome Biol 5 (2): 207.
16. Davis, S., Aldrich, T. H., Jones, P. F., Acheson, A., Compton, D. L., Jain, V., Ryan, T. E., Bruno, J., Radziejewski, C., Maisonpierre, P. C. and Yancopoulos, G. D. (1996). Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87 (7): 1161-9.
17. Del Curling, O. Jr., Kelly, D. L., Jr. Elster, A. D. and Craven, T. E. (1991). An analysis of the natural history of cavernous angiomas. J Neurosurg 75 (5): 702-8.
18. Derhaag, J. G., Duijvestijn, A. M., Emeis, J. J., Engels, W. and van Breda Vriesman, P. J. (1996). Production and characterization of spontaneous rat heart endothelial cell lines. Lab Invest 74 (2): 437-51.
19. Derhaag, J. G., Duijvestijn, A. M. and Van Breda Vriesman, P. J. (1997). Heart EC respond heterogeneous on cytokine stimulation in ICAM-1 and VCAM-1, but not in MHC expression. A study with 3 rat heart endothelial cell (RHEC) lines. Endothelium 5 (4): 307-19.
20. Djonov, V. G., Kurz, H. and Burri, P. H. (2002). Optimality in the developing vascular system: branching remodeling by means of intussusception as an efficient adaptation mechanism. Dev Dyn 224 (4): 391-402.
21. Dmitriev, I., Krasnykh, V., Miller, C. R., Wang, M., Kashentseva, E., Mikheeva, G., Belousova, N. and Curiel, D. T. (1998). An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J Virol 72 (12): 9706-13.
22. Dor, Y., Djonov, V., Abramovitch, R., Itin, A., Fishman, G. I., Carmeliet, P., Goelman, G. and Keshet, E. (2002). Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy. EMBO J 21 (8): 1939-47.
23. Egginton, S., Zhou, A. L., Brown, M. D. and Hudlicka, O. (2001). Unorthodox angiogenesis in skeletal muscle. Cardiovasc Res 49 (3): 634-46.
24. Fong, G. H., Zhang, L., Bryce, D. M. and Peng, J. (1999). Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice. Development 126 (13): 3015-25.
25. Gault, J., Sarin, H., Awadallah, N. A., Shenkar, R. and Awad, I. A. (2004). Pathobiology of human cerebrovascular malformations: basic mechanisms and clinical relevance. Neurosurgery 55 (1): 1-16; discussion 16-7.
26. Gerber, H. P., Hillan, K. J., Ryan, A. M., Kowalski, J., Keller, G. A., Rangell, L., Wright, B. D., Radtke, F., Aguet, M. and Ferrara, N. (1999). VEGF is required for growth and survival in neonatal mice. Development 126 (6): 1149-59.
27. Gering, M., Rodaway, A. R., Gottgens, B., Patient, R. K. and Green, A. R. (1998). The SCL gene specifies haemangioblast development from early mesoderm. EMBO J 17 (14): 4029-45.
28. Gittenberger-de Groot, A. C., DeRuiter, M. C., Bergwerff, M. and Poelmann, R. E. (1999). Smooth muscle cell origin and its relation to heterogeneity in development and disease. Arterioscler Thromb Vasc Biol 19 (7): 1589-94.
29. Gupta, M. K. and Qin, R. Y. (2003). Mechanism and its regulation of tumor-induced angiogenesis. World J Gastroenterol 9 (6): 1144-55.
30. Hall, C. J., Flores, M. V., Davidson, A. J., Crosier, K. E. and Crosier, P. S. (2002). Radar is required for the establishment of vascular integrity in the zebrafish. Dev Biol 251 (1): 105-17.
31. Hanahan, D. (1997). Signaling vascular morphogenesis and maintenance. Science 277 (5322): 48-50.
32. Harrigan, M. R. (2003). Angiogenic factors in the central nervous system. Neurosurgery 53 (3): 639-60; discussion 660-1.
33. Hartmann, A., Mast, H., Mohr, J. P., Koennecke, H. C., Osipov, A., Pile-Spellman, J., Duong, D. H. and Young, W. L. (1998). Morbidity of intracranial hemorrhage in patients with cerebral arteriovenous malformation. Stroke 29 (5): 931-4.
34. Hellstrom, M., Gerhardt, H., Kalen, M., Li, X., Eriksson, U., Wolburg, H. and Betsholtz, C. (2001). Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol 153 (3): 543-53.
35. Hillebrands, J. L., Klatter, F. A., van den Hurk, B. M., Popa, E. R., Nieuwenhuis, P. and Rozing, J. (2001). Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis. J Clin Invest 107 (11): 1411-22.
36. Hojo, M., Hoshimaru, M., Miyamoto, S., Taki, W., Nagata, I., Asahi, M., Matsuura, N., Ishizaki, R., Kikuchi, H. and Hashimoto, N. (1998). Role of transforming growth factor-beta1 in the pathogenesis of moyamoya disease. J Neurosurg 89 (4): 623-9.
37. Holash, J., Maisonpierre, P. C., Compton, D., Boland, P., Alexander, C. R., Zagzag, D., Yancopoulos, G. D. and Wiegand, S. J. (1999). Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284 (5422): 1994-8.
38. Holash, J., Wiegand, S. J. and Yancopoulos, G. D. (1999). New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18 (38): 5356-62.
39. Hood, J. D., Bednarski, M., Frausto, R., Guccione, S., Reisfeld, R. A., Xiang, R. and Cheresh, D. A. (2002). Tumor regression by targeted gene delivery to the neovasculature. Science 296 (5577): 2404-7.
40. Hood, J. D. and Cheresh, D. A. (2002). Role of integrins in cell invasion and migration. Nat Rev Cancer 2 (2): 91-100.
41. Houkin, K., Abe, H., Yoshimoto, T. and Takahashi, A. (1996). Is "unilateral" moyamoya disease different from moyamoya disease? J Neurosurg 85 (5): 772-6.
42. Hynes, R. O. (1992). Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69 (1): 11-25.
43. Hynes, R. O. (2002). A reevaluation of integrins as regulators of angiogenesis. Nat Med 8 (9): 918-21.
44. Jackson, C. (2002). Matrix metalloproteinases and angiogenesis. Curr Opin Nephrol Hypertens 11 (3): 295-9.
45. Jenkinson, L., Bardhan, K. D., Atherton, J. and Kalia, N. (2002). Helicobacter pylori prevents proliferative stage of angiogenesis in vitro : role of cytokines. Dig Dis Sci 47 (8): 1857-62.
46. Jones, N. and Dumont, D. J. (2000). Tek/Tie2 signaling: new and old partners. Cancer Metastasis Rev 19 (1-2): 13-7.
47. Kang, D. H., Anderson, S., Kim, Y. G., Mazzalli, M., Suga, S., Jefferson, J. A., Gordon, K. L., Oyama, T. T., Hughes, J., Hugo, C., Kerjaschki, D., Schreiner, G. F. and Johnson, R. J. (2001). Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis 37 (3): 601-11.
48. Kearney, J. B., Ambler, C. A., Monaco, K. A., Johnson, N., Rapoport, R. G. and Bautch, V. L. (2002). Vascular endothelial growth factor receptor Flt-1 negatively regulates developmental blood vessel formation by modulating endothelial cell division. Blood 99 (7): 2397-407.
49. Kimelman, D., Abraham, J. A., Haaparanta, T., Palisi, T. M. and Kirschner, M. W. (1988). The presence of fibroblast growth factor in the frog egg: its role as a natural mesoderm inducer. Science 242 (4881): 1053-6.
50. Kontos, C. D. and Annex, B. H. (1999). Angiogenesis. Curr Atheroscler Rep 1 (2): 165-71.
51. Kostoulas, G., Lang, A., Nagase, H. and Baici, A. (1999). Stimulation of angiogenesis through cathepsin B inactivation of the tissue inhibitors of matrix metalloproteinases. FEBS Lett 455 (3): 286-90.
52. Kubo, H. (1993). Angiogenesis on encephalo-myo-synangiosis. The effect of basic fibroblast growth factor. Nippon Geka Hokan 62 (2): 82-91.
53. Kusaka, N., Sugiu, K., Tokunaga, K., Katsumata, A., Nishida, A., Namba, K., Hamada, H., Nakashima, H. and Date, I. (2005). Enhanced brain angiogenesis in chronic cerebral hypoperfusion after administration of plasmid human vascular endothelial growth factor in combination with indirect vasoreconstructive surgery. J Neurosurg 103 (5): 882-90.
54. LeCouter, J., Kowalski, J., Foster, J., Hass, P., Zhang, Z., Dillard-Telm, L., Frantz, G., Rangell, L., DeGuzman, L., Keller, G. A., Peale, F., Gurney, A., Hillan, K. J. and Ferrara, N. (2001). Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 412 (6850): 877-84.
55. Liao, E. C., Paw, B. H., Oates, A. C., Pratt, S. J., Postlethwait, J. H. and Zon, L. I. (1998). SCL/Tal-1 transcription factor acts downstream of cloche to specify hematopoietic and vascular progenitors in zebrafish. Genes Dev 12 (5): 621-6.
56. Liao, W., Ho, C. Y., Yan, Y. L., Postlethwait, J. and Stainier, D. Y. (2000). Hhex and scl function in parallel to regulate early endothelial and blood differentiation in zebrafish. Development 127 (20): 4303-13.
57. Lim, M., Haddix, T., Harsh, G. R., Vogel, H., Steinberg, G. K. and Guccione, S. (2005). Characterization of the integrin alpha v beta3 in arteriovenous malformations and cavernous malformations. Cerebrovasc Dis 20 (1): 23-7.
58. Lopes, M. B. (2003). Angiogenesis in brain tumors. Microsc Res Tech 60 (2): 225-30.
59. Luttun, A. and Carmeliet, P. (2004). Angiogenesis and lymphangiogenesis: highlights of the past year. Curr Opin Hematol 11 (4): 262-71.
60. Luttun, A., Dewerchin, M., Collen, D. and Carmeliet, P. (2000). The role of proteinases in angiogenesis, heart development, restenosis, atherosclerosis, myocardial ischemia, and stroke: insights from genetic studies. Curr Atheroscler Rep 2 (5): 407-16.
61. Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., Daly, T. J., Davis, S., Sato, T. N. and Yancopoulos, G. D. (1997). Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277 (5322): 55-60.
62. Malek, A. M., Connors, S., Robertson, R. L., Folkman, J. and Scott, R. M. (1997). Elevation of cerebrospinal fluid levels of basic fibroblast growth factor in moyamoya and central nervous system disorders. Pediatr Neurosurg 27 (4): 182-9.
63. Mast, H., Young, W. L., Koennecke, H. C., Sciacca, R. R., Osipov, A., Pile-Spellman, J., Hacein-Bey, L., Duong, H., Stein, B. M. and Mohr, J. P. (1997). Risk of spontaneous haemorrhage after diagnosis of cerebral arteriovenous malformation. Lancet 350 (9084): 1065-8.
64. McColl, B. K., Stacker, S. A. and Achen, M. G. (2004). Molecular regulation of the VEGF family - inducers of angiogenesis and lymphangiogenesis. APMIS 112 (7-8): 463-80.
65. Mergia, A., Eddy, R., Abraham, J. A., Fiddes, J. C. and Shows, T. B. (1986). The genes for basic and acidic fibroblast growth factors are on different human chromosomes. Biochem Biophys Res Commun 138 (2): 644-51.
66. Meyer, M., Clauss, M., Lepple-Wienhues, A., Waltenberger, J., Augustin, H. G., Ziche, M., Lanz, C., Buttner, M., Rziha, H. J. and Dehio, C. (1999). A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. EMBO J 18 (2): 363-74.
67. Miao, R. Q., Agata, J., Chao, L. and Chao, J. (2002). Kallistatin is a new inhibitor of angiogenesis and tumor growth. Blood 100 (9): 3245-52.
68. Mikkola, H. K. and Orkin, S. H. (2002). The search for the hemangioblast. J Hematother Stem Cell Res 11 (1): 9-17.
69. Moyon, D., Pardanaud, L., Yuan, L., Breant, C. and Eichmann, A. (2001). Plasticity of endothelial cells during arterial-venous differentiation in the avian embryo. Development 128 (17): 3359-70.
70. Nemerow, G. R. and Stewart, P. L. (1999). Role of alpha (v) integrins in adenovirus cell entry and gene delivery. Microbiol Mol Biol Rev 63 (3): 725-34.
71. Ondrick, K. and Samojla, B. G. (1992). Angiogenesis. Clin Podiatr Med Surg 9 (1): 185-202.
72. Ornitz, D. M. and Itoh, N. (2001). Fibroblast growth factors. Genome Biol 2 (3): REVIEWS3005.
73. Othman-Hassan, K., Patel, K., Papoutsi, M., Rodriguez-Niedenfuhr, M., Christ, B. and Wilting, J. (2001). Arterial identity of endothelial cells is controlled by local cues. Dev Biol 237 (2): 398-409.
74. Pardanaud, L., Luton, D., Prigent, M., Bourcheix, L. M., Catala, M. and Dieterlen-Lievre, F. (1996). Two distinct endothelial lineages in ontogeny, one of them related to hemopoiesis. Development 122 (5): 1363-71.
75. Pepper, M. S. (2001). Extracellular proteolysis and angiogenesis. Thromb Haemost 86 (1): 346-55.
76. Powers, C. J., McLeskey, S. W. and Wellstein, A. (2000). Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 7 (3): 165-97.
77. Presta, M., Dell'Era, P., Mitola, S., Moroni, E., Ronca, R. and Rusnati, M. (2005). Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev 16 (2): 159-78.
78. Reuss, B., Dermietzel, R. and Unsicker, K. (1998). Fibroblast growth factor 2 (FGF-2) differentially regulates connexin (cx) 43 expression and function in astroglial cells from distinct brain regions. Glia 22 (1): 19-30.
79. Reuss, B., Hertel, M., Werner, S. and Unsicker, K. (2000). Fibroblast growth factors-5 and -9 distinctly regulate expression and function of the gap junction protein connexin43 in cultured astroglial cells from different brain regions. Glia 30 (3): 231-41.
80. Reuss, B. and von Bohlen und Halbach, O. (2003). Fibroblast growth factors and their receptors in the central nervous system. Cell Tissue Res 313 (2): 139-57.
81. Robinson, J. R., Awad, I. A. and Little, J. R. (1991). Natural history of the cavernous angioma. J Neurosurg 75 (5): 709-14.
82. Rovainen, C. M. (1991). Labeling of developing vascular endothelium after injections of rhodamine-dextran into blastomeres of Xenopus laevis. J Exp Zool 259 (2): 209-21.
83. Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X. F., Breitman, M. L. and Schuh, A. C. (1995). Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376 (6535): 62-6.
84. Shenkar, R., Elliott, J. P., Diener, K., Gault, J., Hu, L. J., Cohrs, R. J., Phang, T., Hunter, L., Breeze, R. E. and Awad, I. A. (2003). Differential gene expression in human cerebrovascular malformations. Neurosurgery 52 (2): 465-77; discussion 477-8.
85. Shintani, S., Murohara, T., Ikeda, H., Ueno, T., Honma, T., Katoh, A., Sasaki, K., Shimada, T., Oike, Y. and Imaizumi, T. (2001). Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103 (23): 2776-9.
86. Siegel, A. M., Bertalanffy, H., Dichgans, J. J., Elger, C. E., Hopf, H., Hopf, N., Keidel, M., Kleider, A., Nowak, G., Pfeiffer, R. A., Schramm, J., Spuck, S., Stefan, H., Sure, U., Baumann, C. R., Rouleau, G. A., Verlaan, D. J., Andermann, E. and Andermann, F. (2005). Familial cavernous malformations of the central nervous system. A clinical and genetic study of 15 German families. Nervenarzt 76 (2): 175-80.
87. Stewart, P. L., Chiu, C. Y., Huang, S., Muir, T., Zhao, Y., Chait, B., Mathias, P. and Nemerow, G. R. (1997). Cryo-EM visualization of an exposed RGD epitope on adenovirus that escapes antibody neutralization. EMBO J 16 (6): 1189-98.
88. Swerlick, R. A. (1995). Angiogenesis. J Dermatol 22 (11): 845-52.
89. Takahashi, A., Sawamura, Y., Houkin, K., Kamiyama, H. and Abe, H. (1993). The cerebrospinal fluid in patients with moyamoya disease (spontaneous occlusion of the circle of Willis) contains high level of basic fibroblast growth factor. Neurosci Lett 160 (2): 214-6.
90. Takahashi, T., Kalka, C., Masuda, H., Chen, D., Silver, M., Kearney, M., Magner, M., Isner, J. M. and Asahara, T. (1999). Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5 (4): 434-8.
91. Takekawa, Y., Umezawa, T., Ueno, Y., Sawada, T. and Kobayashi, M. (2004). Pathological and immunohistochemical findings of an autopsy case of adult moyamoya disease. Neuropathology 24 (3): 236-42.
92. Visconti, R. P., Richardson, C. D. and Sato, T. N. (2002). Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF). Proc Natl Acad Sci USA 99 (12): 8219-24.
93. Ward, N. L. and Dumont, D. J. (2002). The angiopoietins and Tie2/Tek: adding to the complexity of cardiovascular development. Semin Cell Dev Biol 13 (1): 19-27.
94. Wickham, T. J., Mathias, P., Cheresh, D. A. and Nemerow, G. R. (1993). Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73 (2): 309-19.
95. Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J. and Holash, J. (2000). Vascular-specific growth factors and blood vessel formation. Nature 407 (6801): 242-8.
96. Yano, A., Shingo, T., Takeuchi, A., Yasuhara, T., Kobayashi, K., Takahashi, K., Muraoka, K., Matsui, T., Miyoshi, Y., Hamada, H. and Date, I. (2005). Encapsulated vascular endothelial growth factor-secreting cell grafts have neuroprotective and angiogenic effects on focal cerebral ischemia. J Neurosurg 103 (1): 104-14.
97. Yasuhara, T., Shingo, T. and Date, I. (2004). The potential role of vascular endothelial growth factor in the central nervous system. Rev Neurosci 15 (4): 293-307.
98. Yoshimoto, T., Houkin, K., Takahashi, A. and Abe, H. (1996). Angiogenic factors in moyamoya disease. Stroke 27 (12): 2160-5.
99. Yoshimoto, T., Houkin, K., Takahashi, A. and Abe, H. (1997). Evaluation of cytokines in cerebrospinal fluid from patients with moyamoya disease. Clin Neurol Neurosurg 99 (Suppl 2): S218-20.
100. Yousef, G. M. and Diamandis, E. P. (2002). Expanded human tissue kallikrein family - a novel panel of cancer biomarkers. Tumour Biol 23 (3): 185-92.
101. Zadeh, G. and Guha, A. (2003a). Angiogenesis in nervous system disorders. Neurosurgery 53 (6): 1362-74; discussion 1374-6.
102. Zadeh, G. and Guha, A. (2003b). Neoangiogenesis in human astrocytomas: expression and functional role of angiopoietins and their cognate receptors. Front Biosci 8: e128-37.